147 related articles for article (PubMed ID: 21073436)
1. Recent patents of DNA methylation biomarkers in gastrointestinal oncology.
Corvalan AH; Maturana MJ
Recent Pat DNA Gene Seq; 2010 Nov; 4(3):202-9. PubMed ID: 21073436
[TBL] [Abstract][Full Text] [Related]
2. Epigenomic biomarkers for prognostication and diagnosis of gastrointestinal cancers.
Wong CC; Li W; Chan B; Yu J
Semin Cancer Biol; 2019 Apr; 55():90-105. PubMed ID: 29665409
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation detection technology and plasma-based methylation biomarkers in screening of gastrointestinal carcinoma.
Cao M; Zhang C; Zhou L
Epigenomics; 2021 Aug; 13(16):1327-1339. PubMed ID: 34369810
[TBL] [Abstract][Full Text] [Related]
4. Molecular Detection of Gastrointestinal Neoplasia: Innovations in Early Detection and Screening.
Anderson BW; Ahlquist DA
Gastroenterol Clin North Am; 2016 Sep; 45(3):529-42. PubMed ID: 27546847
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic Alterations in the Gastrointestinal Tract: Current and Emerging Use for Biomarkers of Cancer.
Grady WM; Yu M; Markowitz SD
Gastroenterology; 2021 Feb; 160(3):690-709. PubMed ID: 33279516
[TBL] [Abstract][Full Text] [Related]
6. EpiPanGI Dx: A Cell-free DNA Methylation Fingerprint for the Early Detection of Gastrointestinal Cancers.
Kandimalla R; Xu J; Link A; Matsuyama T; Yamamura K; Parker MI; Uetake H; Balaguer F; Borazanci E; Tsai S; Evans D; Meltzer SJ; Baba H; Brand R; Von Hoff D; Li W; Goel A
Clin Cancer Res; 2021 Nov; 27(22):6135-6144. PubMed ID: 34465601
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation markers in patients with gastrointestinal cancers. Current understanding, potential applications for disease management and development of diagnostic tools.
Lofton-Day C; Lesche R
Dig Dis; 2003; 21(4):299-308. PubMed ID: 14752219
[TBL] [Abstract][Full Text] [Related]
8. SPARC and DNA methylation: possible diagnostic and therapeutic implications in gastrointestinal cancers.
Nagaraju GP; El-Rayes BF
Cancer Lett; 2013 Jan; 328(1):10-7. PubMed ID: 22939997
[TBL] [Abstract][Full Text] [Related]
9. Epigenomic profiling of non-small cell lung cancer xenografts uncover LRP12 DNA methylation as predictive biomarker for carboplatin resistance.
Grasse S; Lienhard M; Frese S; Kerick M; Steinbach A; Grimm C; Hussong M; Rolff J; Becker M; Dreher F; Schirmer U; Boerno S; Ramisch A; Leschber G; Timmermann B; Grohé C; Lüders H; Vingron M; Fichtner I; Klein S; Odenthal M; Büttner R; Lehrach H; Sültmann H; Herwig R; Schweiger MR
Genome Med; 2018 Jul; 10(1):55. PubMed ID: 30029672
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectives.
Vedeld HM; Goel A; Lind GE
Semin Cancer Biol; 2018 Aug; 51():36-49. PubMed ID: 29253542
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation profiling of esophageal adenocarcinoma using Methylation Ligation-dependent Macroarray (MLM).
Guilleret I; Losi L; Chelbi ST; Fonda S; Bougel S; Saponaro S; Gozzi G; Alberti L; Braunschweig R; Benhattar J
Biochem Biophys Res Commun; 2016 Oct; 479(2):231-237. PubMed ID: 27634218
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic inactivation of FAT4 contributes to gastric field cancerization.
Yoshida S; Yamashita S; Niwa T; Mori A; Ito S; Ichinose M; Ushijima T
Gastric Cancer; 2017 Jan; 20(1):136-145. PubMed ID: 26792292
[TBL] [Abstract][Full Text] [Related]
13. Aberrant DNA methylation associated with aggressiveness of gastrointestinal stromal tumour.
Okamoto Y; Sawaki A; Ito S; Nishida T; Takahashi T; Toyota M; Suzuki H; Shinomura Y; Takeuchi I; Shinjo K; An B; Ito H; Yamao K; Fujii M; Murakami H; Osada H; Kataoka H; Joh T; Sekido Y; Kondo Y
Gut; 2012 Mar; 61(3):392-401. PubMed ID: 21708825
[TBL] [Abstract][Full Text] [Related]
14. Molecular biomarkers in esophageal, gastric, and colorectal adenocarcinoma.
Tänzer M; Liebl M; Quante M
Pharmacol Ther; 2013 Nov; 140(2):133-47. PubMed ID: 23791941
[TBL] [Abstract][Full Text] [Related]
15. Identification of prognostic DNA methylation biomarkers in patients with gastrointestinal adenocarcinomas: A systematic review of epigenome-wide studies.
d'Errico M; Alwers E; Zhang Y; Edelmann D; Brenner H; Hoffmeister M
Cancer Treat Rev; 2020 Jan; 82():101933. PubMed ID: 31785412
[TBL] [Abstract][Full Text] [Related]
16. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development.
Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W
Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858
[TBL] [Abstract][Full Text] [Related]
17. Epigenetics: DNA Methylation Analysis in Esophageal Adenocarcinoma.
Islam F; Tang JC; Gopalan V; Lam AK
Methods Mol Biol; 2018; 1756():247-256. PubMed ID: 29600375
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation mediated silencing of microRNA-145 is a potential prognostic marker in patients with lung adenocarcinoma.
Xia W; Chen Q; Wang J; Mao Q; Dong G; Shi R; Zheng Y; Xu L; Jiang F
Sci Rep; 2015 Nov; 5():16901. PubMed ID: 26582602
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation patterns as noninvasive biomarkers and targets of epigenetic therapies in colorectal cancer.
Hashimoto Y; Zumwalt TJ; Goel A
Epigenomics; 2016 May; 8(5):685-703. PubMed ID: 27102979
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic biomarkers in the blood of patients with urological malignancies.
Ellinger J; Müller SC; Dietrich D
Expert Rev Mol Diagn; 2015 Apr; 15(4):505-16. PubMed ID: 25719388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
